Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer’s disease

Low Levels of Antibodies Against Phosphorylcholine in Alzheimer's Disease

(2017) Ulrika K. Eriksson et al.   JOURNAL OF ALZHEIMERS DISEASE

A turning point for Alzheimer's disease?

(2012) Jack C. de la Torre   BIOFACTORS

Does vascular pathology contribute to Alzheimer changes?

(2012) Raj N. Kalaria et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Low Levels of Antibodies Against Phosphorylcholine Predict Development of Stroke in a Population-Based Study From Northern Sweden

(2010) Roland Fiskesund et al.   STROKE

Low level natural antibodies against phosphorylcholine: A novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease

(2009) Johan Frostegård   CLINICAL IMMUNOLOGY

Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden

(2009) Hans Grönlund et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: Effects on uptake of oxidized LDL in macrophages as a potential mechanism

(2009) Ulf de Faire et al.   JOURNAL OF AUTOIMMUNITY

Vascular risk factors and dementia: How to move forward?

(2009) A. Viswanathan et al.   NEUROLOGY

Low levels of IgM antibodies against phosphorylcholine—A potential risk marker for ischemic stroke in men

(2008) Beatrice G. Sjöberg et al.   ATHEROSCLEROSIS

Cognition and diabetes: a lifespan perspective

(2008) Geert Jan Biessels et al.   LANCET NEUROLOGY